Pinealon

Pinealon is a synthetic tripeptide bioregulator developed by the St. Petersburg Institute of Bioregulation and Gerontology as part of their extensive research into short regulatory peptides. The compound was designed to support pineal gland function and has demonstrated effects on melatonin production, circadian rhythm regulation, and cognitive processes.

The pineal gland is a neuroendocrine organ that produces melatonin and plays a central role in circadian rhythm regulation, sleep-wake cycles, and seasonal biological rhythms. Pineal function declines with age, contributing to sleep disturbances, circadian disruption, and potentially accelerated aging processes.

Research suggests pinealon's mechanism involves interaction with DNA and regulation of gene expression in pinealocytes and neural tissue. Studies have demonstrated that short peptides like pinealon can penetrate cell membranes and nuclear envelopes, potentially interacting with specific DNA sequences to modulate transcription of genes involved in melatonin synthesis and neuronal function.

Animal and cell culture studies have shown pinealon increases melatonin production, improves antioxidant enzyme activity, and protects neurons against oxidative stress damage. Clinical research in elderly populations reports improvements in sleep quality, cognitive function, and circadian rhythm stability following pinealon administration, positioning it as a candidate for healthy aging interventions.